Delivery Order SPE2DB24D2205-SPE2DB25FDZGR

Award Date 3/6/25
Potential Completion Date 3/27/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for the supply of ESBRIET 267 MG CAPSULE 270S, a prescription medication. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 delivery order contract is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has a ceiling value of $3,425.95 and runs through March 20, 2025. The contract is a firm fixed-price delivery order and does not have any set-aside requirements. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price delivery order contract covers the provision of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, with a performance period through January 30, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed price delivery order is for the drug ESBRIET 267 MG CAPSULE 270S, with a performance period ending on March 12, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 delivery order is for ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, with a firm fixed price and an ultimate completion date of December 24, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,311.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564530452 ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, with a completion date of May 29, 2024. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) with delivery orders for ESBRIET 267 MG CAPSULE 270S, a specialty pharmaceutical product. The contract has a ceiling value of $3,425.95 and runs through January 28, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,425.95 firm fixed-price delivery order contract covers the supply of ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025 and was awarded on December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDZGR
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $10,277.85 firm fixed price delivery order contract is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not include any set-aside designation, indicating open competition.

Generated 6/5/25, 10:02 AM